A backlog of 78 billion euros and a stock down roughly 46% in a year rarely belong in the same sentence. They do at Rheinmetall, Germany's defense champion, which just trimmed its 2026 outlook for the second time since August. The episode is a useful reminder that a great demand story and a great investment are two different things, and that the gap between them is often timing.
The numbers show the tension. Management now expects 2026 sales of about 13.2 billion euros, below the earlier 13.7 to 14.2 billion euro range, with an operating margin near 18.5% instead of 19%. The causes are not collapsing demand but friction: Germany's Arminius program for Boxer armored vehicles slipped into next year, and artillery ammunition acceptance testing ran late. Those delays also push customer advance payments into 2027, which weighs on a cash conversion target that had been above 40%, although operating free cash flow is still expected to be positive.
Meanwhile, the underlying business keeps growing. Third-quarter sales rose 32% to 3.15 billion euros, and operating profit jumped 62% to 553 million euros. Order intake of 2.89 billion euros kept the backlog at 78 billion. Yet the shares fell more than 17% on the day, a steep reset for a stock that averaged gains of about 119% a year over the prior four years. When a share price has compounded that quickly, expectations leave almost no room for administrative slippage, and every delayed contract is punished as if it were a lost one.
There is a second, less visible risk. Analysts at RBC flagged a broader 'new-tech versus old-tech' debate in defense, where investors question whether traditional armored vehicles and artillery will keep their share of budgets as drones and software-defined systems gain ground. Rheinmetall's partnership with Destinus is aimed at exactly that shift, but even this new business saw some fourth-quarter revenue pushed back. A moat built on large government programs is real, yet it comes with lumpy, politically scheduled revenue that no management team fully controls.
So what for long-term investors? First, a rising backlog is not the same as predictable earnings, because the conversion of orders into sales and cash depends on procurement calendars. Second, after a 119% annual run, the starting valuation matters more than the narrative, and a drawdown of this size is a lesson in what happens when a multiple assumes perfection. Third, the real question to ask is whether the multi-year spending commitments across Europe remain intact, and whether the company's capacity, margins and cash generation can catch up with them. If the answer is yes, today's delays may prove to be noise. If the answer is no, the 46% decline may only be the beginning of a more sober repricing of the whole sector.